HK1062689A1 - High-affinity antagonists of elr-cxc chemokines - Google Patents

High-affinity antagonists of elr-cxc chemokines

Info

Publication number
HK1062689A1
HK1062689A1 HK04103755A HK04103755A HK1062689A1 HK 1062689 A1 HK1062689 A1 HK 1062689A1 HK 04103755 A HK04103755 A HK 04103755A HK 04103755 A HK04103755 A HK 04103755A HK 1062689 A1 HK1062689 A1 HK 1062689A1
Authority
HK
Hong Kong
Prior art keywords
elr
cxc chemokines
affinity antagonists
antagonists
affinity
Prior art date
Application number
HK04103755A
Other languages
English (en)
Inventor
John R Gordon
Fang Li
Original Assignee
Univ Saskatchewan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Saskatchewan filed Critical Univ Saskatchewan
Publication of HK1062689A1 publication Critical patent/HK1062689A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5421—IL-8
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Production Of Liquid Hydrocarbon Mixture For Refining Petroleum (AREA)
  • Power Steering Mechanism (AREA)
HK04103755A 2001-03-01 2004-05-27 High-affinity antagonists of elr-cxc chemokines HK1062689A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27318101P 2001-03-01 2001-03-01
PCT/CA2002/000271 WO2002070565A2 (en) 2001-03-01 2002-03-01 High-affinity antagonists of elr-cxc chemokines

Publications (1)

Publication Number Publication Date
HK1062689A1 true HK1062689A1 (en) 2004-11-19

Family

ID=23042842

Family Applications (1)

Application Number Title Priority Date Filing Date
HK04103755A HK1062689A1 (en) 2001-03-01 2004-05-27 High-affinity antagonists of elr-cxc chemokines

Country Status (11)

Country Link
US (3) US7201895B2 (xx)
EP (1) EP1363944B1 (xx)
JP (1) JP2004534521A (xx)
AT (1) ATE339447T1 (xx)
AU (1) AU2002237136B2 (xx)
CA (1) CA2439452C (xx)
DE (1) DE60214676T2 (xx)
DK (1) DK1363944T3 (xx)
ES (1) ES2274957T3 (xx)
HK (1) HK1062689A1 (xx)
WO (1) WO2002070565A2 (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1363944B1 (en) 2001-03-01 2006-09-13 University of Saskatchewan Technologies Inc. High-affinity antagonists of elr-cxc chemokines
ATE530650T1 (de) * 2006-05-16 2011-11-15 Univ Saskatchewan Hochaffine antagonisten von elr-cxc-chemokinen
US8299019B2 (en) * 2008-02-12 2012-10-30 Gordon John R Uses of modified ELR-CXC chemokine G31P to treat cancer
US8252741B2 (en) 2008-02-12 2012-08-28 Gordon John R Uses of modified ELR-CXC chemokine G31P
KR101247641B1 (ko) 2010-10-22 2013-03-29 성균관대학교산학협력단 Ｃｘｃｒ２에 결합하는 펩타이드 리간드를 포함하는 감염성 및 염증성 질환 치료용 조성물
CN103619836A (zh) 2011-03-03 2014-03-05 德诺瓦姆德有限公司 抗菌剂/抗菌佐剂化合物及其方法
ES2811527T3 (es) 2013-06-18 2021-03-12 Univ New York Composiciones farmacéuticas que contienen una leucocidina E mutada
US10075024B2 (en) 2015-05-22 2018-09-11 La-Z-Boy Incorporated Apparatus and method for wireless power transfer in furniture
EP4252629A3 (en) 2016-12-07 2023-12-27 Biora Therapeutics, Inc. Gastrointestinal tract detection methods, devices and systems
EP3554541B1 (en) 2016-12-14 2023-06-07 Biora Therapeutics, Inc. Treatment of a disease of the gastrointestinal tract with a chemokine/chemokine receptor inhibitor
CN109022599A (zh) * 2018-10-08 2018-12-18 河南科技学院 检测奶牛CCL28基因单核苷酸多态性的试剂盒及RFLP方法及相关SNPs
KR20210095165A (ko) 2018-11-19 2021-07-30 프로제너티, 인크. 바이오의약품으로 질환을 치료하기 위한 방법 및 디바이스
CN115666704A (zh) 2019-12-13 2023-01-31 比奥拉治疗股份有限公司 用于将治疗剂递送至胃肠道的可摄取装置

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE169638T1 (de) * 1991-12-04 1998-08-15 Biomedical Res Centre Ltd Analoge des menschlichen interleukin-8.
AU6283996A (en) * 1995-06-20 1997-01-22 Chiron Corporation Polypeptides with interleukin-8 receptor binding
EP1363944B1 (en) * 2001-03-01 2006-09-13 University of Saskatchewan Technologies Inc. High-affinity antagonists of elr-cxc chemokines

Also Published As

Publication number Publication date
US20070021593A1 (en) 2007-01-25
US7741434B2 (en) 2010-06-22
US20090118469A1 (en) 2009-05-07
DE60214676D1 (de) 2006-10-26
CA2439452A1 (en) 2002-09-12
US20030077705A1 (en) 2003-04-24
WO2002070565A9 (en) 2002-10-31
EP1363944B1 (en) 2006-09-13
WO2002070565A3 (en) 2002-12-19
CA2439452C (en) 2012-05-15
ES2274957T3 (es) 2007-06-01
AU2002237136B2 (en) 2007-11-01
JP2004534521A (ja) 2004-11-18
US7201895B2 (en) 2007-04-10
WO2002070565A2 (en) 2002-09-12
EP1363944A2 (en) 2003-11-26
DE60214676T2 (de) 2007-09-20
ATE339447T1 (de) 2006-10-15
DK1363944T3 (da) 2007-01-08

Similar Documents

Publication Publication Date Title
TW200631594A (en) Toll like receptor 3 antagonists, methods and uses
HK1062689A1 (en) High-affinity antagonists of elr-cxc chemokines
SG157952A1 (en) Small molecule antagonists of bcl-2 family proteins
BR0008688A (pt) Antagonistas de il-18 recombinantes utilizáveis no tratamento de distúrbios mediados por il-18
SG158141A1 (en) Pancreatic polypeptide family motifs, polypeptides and methods comprising the same
GB0115862D0 (en) Compounds
AU2002350961A1 (en) Ethylene diamine derivatives and their use as orexin-receptor antagonists
MX337423B (es) Antagonistas anti-beta7 humanizados y usos para los mismos.
EP1357909A4 (en) ANTAGONISTS OF IL-8 RECEPTORS
WO2003029271A3 (en) Novel nucleic acids and polypeptides
WO2003104425A3 (en) NEW STABLE ANTI-CD22 ANTIBODIES
IL152411A0 (en) Zolpidem hemitartrate
AU2002358390A1 (en) Novel compounds
MXPA03007635A (es) P-tienilbencilamidas que sirven como agonistas de receptores para angiotensina-(1-7), metodo para su produccion, su uso y preparaciones farmaceuticas que las contienen.
WO2004007664A3 (en) Nucleic acid vectors
WO2003002604A3 (en) G protein coupled receptors and dna sequences thereof
WO2003018798A3 (en) G-protein coupled receptor and dna sequences thereof
WO2004083381A3 (en) Fibroblast growth factor receptor-1 polynucleotides, polypeptides, and mutants
MXPA04000541A (es) Formulacion liofilizada de 2-metil-tieno-benzodiazepina.
WO2005037236A3 (en) Novel heat shock protein 20-related polypeptides and uses therefor
PL374550A1 (en) Il-17 like molecules and uses thereof
MXPA04005176A (es) N-ureido-piperidinas como antagonistas viii para receptores ccr-3.
WO2002088358A3 (en) Human fibroblast growth factor-related compositions
AU2002246123A1 (en) Cloning of the cdna that codes for cup s 1, the major allergen of cupressus sempervirens
MXPA04001166A (es) Usos de citocina de mamifero; reactivos relacionados.

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20130301